Literature DB >> 19954839

Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers.

Phapanin Charoenphol1, Ryan B Huang, Omolola Eniola-Adefeso.   

Abstract

Targeting of drug carriers to the vascular wall is of interest for localized delivery of therapeutics in many human diseases. Nanometer-sized spherical particles are widely proposed for use as carriers for vascular targeting, yet very little evidence has been presented as to their ability to interact with the vascular wall. Thus, this work focuses on elucidating the effect of particle size along with hemodynamics, blood rheology, and vessel size on the adhesion efficiency of targeted polymeric spheres to inflamed endothelium in vitro via parallel plate flow chamber assays. We find that the binding efficiency of spheres to the endothelium from blood flow generally increased with increasing particle size, wall shear rate and channel height for particle sizes from 100 nm up to 10 microm. However, nano-sized particles showed minimal adhesion to the endothelium from blood flow in horizontal (gravity or anti-gravity direction) and vertical channels on the order of small to medium-sized venules and arteries when compared to micron-sized spheres. Furthermore, adhesion of nanospheres was not enhanced with pulsatility in flow. Overall, the presented data suggests that spheres 2-5 microm in size are optimal for targeting the wall in medium to large vessels relevant in several cardiovascular diseases. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954839     DOI: 10.1016/j.biomaterials.2009.11.007

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  70 in total

1.  Strongly Accelerated Margination of Active Particles in Blood Flow.

Authors:  Stephan Gekle
Journal:  Biophys J       Date:  2016-01-19       Impact factor: 4.033

2.  Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.

Authors:  Ying Li; Yanping Lian; Lucy T Zhang; Saad M Aldousari; Hassan S Hedia; Saeed A Asiri; Wing Kam Liu
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

Review 3.  Particle margination and its implications on intravenous anticancer drug delivery.

Authors:  Erik Carboni; Katherine Tschudi; Jaewook Nam; Xiuling Lu; Anson W K Ma
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

Review 4.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

Review 5.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

Review 6.  Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.

Authors:  Portonovo S Ayyaswamy; Vladimir Muzykantov; David M Eckmann; Ravi Radhakrishnan
Journal:  J Nanotechnol Eng Med       Date:  2013-07-11

Review 7.  Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.

Authors:  Khosrow Khodabandehlou; Jacqueline J Masehi-Lano; Christopher Poon; Jonathan Wang; Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

8.  Calcium-binding nanoparticles for vascular disease.

Authors:  Deborah D Chin; Sampreeti Chowdhuri; Eun Ji Chung
Journal:  Regen Eng Transl Med       Date:  2018-10-23

9.  Computational analysis of nanoparticle adhesion to endothelium: effects of kinetic rate constants and wall shear rates.

Authors:  Moon June Kim; Kyehan Rhee
Journal:  Med Biol Eng Comput       Date:  2011-05-10       Impact factor: 2.602

Review 10.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.